Answers are grounded in this paper and cite their sources.
Investigates NOR-1's role in vascular remodeling, indicating its potential as a therapeutic target.
Vascular and cardiac remodeling are dynamic responses to hemodynamic load, neurohumoral activation, and inflammatory stress that determine the transition from adaptive repair to pathological hypertrophy, fibrosis, and neointimal growth. The immediate early nuclear receptor NOR-1 (NR4A3) is rapidly induced by mechanical forces, angiotensin II, β-adrenergic signaling, and cytokines in endothelial cells, vascular smooth muscle cells, and cardiomyocytes. Experimental studies indicate that NOR-1 regulates cell proliferation, inflammatory gene expression, and metabolic programs through context-dependent post-translational modification. Transient induction of NOR-1 under laminar flow or physiological stress has been associated with anti-inflammatory endothelial phenotypes and the maintenance of contractile gene expression. Whereas sustained activation during disturbed flow, pressure overload, or chronic neurohumoral stimulation promotes smooth muscle cell proliferation, extracellular matrix remodeling, and fetal gene reactivation. We discuss a model in which NOR-1 integrates mechanical, metabolic, and inflammatory cues across vascular and cardiac tissues and consider how temporal and cell-specific regulation of NOR-1 might influence disease progression. Clarifying the dynamics of NOR-1 signaling and its chromatin context will be important for evaluating its potential as a biomarker or therapeutic target in cardiometabolic disorders.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: